Wednesday, 7 August 2019
Home »
Health
,
Health news
,
IFTTT
,
NYT
» Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.
Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.
By KATIE THOMAS from NYT Health https://ift.tt/2YPZ7N5
0 comments:
Post a Comment